Top biotech investor says Trump's criticism of Pfizer is scaring drug companies from raising prices
July 23, 2018 at 14:47 PM EDT
Sarissa's Alex Denner says President Trump’s criticism of pharmaceutical giant Pfizer is having an impact on how other companies in health care set their prices.
